Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment
Top Cited Papers
- 1 November 2005
- journal article
- Published by Elsevier BV in Journal of Oral and Maxillofacial Surgery
- Vol. 63 (11), 1567-1575
- https://doi.org/10.1016/j.joms.2005.07.010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Bisphosphonate-Induced OsteopetrosisNew England Journal of Medicine, 2003
- Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic AcidJournal of Pharmacology and Experimental Therapeutics, 2002
- Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogencontaining bisphosphonates on osteoclast precursorsBone, 2002
- Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2aPublished by American Academy of Pediatrics (AAP) ,1999
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Studies in the radiobiology of osteoradionecrosis and their clinical significanceOral Surgery, Oral Medicine, Oral Pathology, 1987
- Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosusAmerican Journal Of Medicine, 1985
- A new concept in the treatment of osteoradionecrosisJournal of Oral and Maxillofacial Surgery, 1983